Hastened development and commercialization of ‘rare drugs’ for rare disease patients

The Ministry of Food and Drug Safety(Minister Seung-hee Kim, MFDS) announced it gave a administrative notice for 6 amendments, such as the ‘Regulation to Indicate Rare Drugs,’ containing the contents to establish active development environments for domestic pharmaceutical companies to develop rare drugs – such as improvement of indication conditions, expansion of reevaluation targets and extens...